Physician

Armin Shahrokni, M.D

According to 2025 Medicare claims, Armin Shahrokni, M.D (NPI: 1376776757) practices geriatric medicine in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is MEMORIAL MEDICAL CONSULTATION GROUP (NPI: 1053382523; TIN: 133278550) and primary practice location at 10021-3402. Shahrokni is affiliated with the JFK Population Health LLC, JFK Health ACO (ACO ID: A2311), participating under the MSSP model.

Shahrokni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 731 traditional Medicare patients, billed 1,242 HCPCS/CPT codes, and received $146,139 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 520 prescription claims across 80 beneficiaries totaling $49,624 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 16 claims. Open Payments data shows 2 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $87,402 and ending at $146,139. Concurrently, Part D prescription costs have fallen sharply in recent years, from $61,139 to $49,624. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $799 and ending at $880.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	405	964	$87,402
2016	421	983	$84,238
2017	423	1,044	$82,410
2018	395	1,213	$88,795
2019	344	1,103	$77,716
2020	362	965	$71,822
2021	378	1,058	$96,872
2022	331	869	$70,936
2023	495	1,192	$120,646
2024	731	1,242	$146,139

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	348	$61,139
2016	83	379	$148,436
2017	82	539	$121,979
2018	120	670	$158,206
2019	96	580	$243,546
2020	86	458	$249,577
2021	93	433	$40,785
2022	90	548	$83,735
2023	56	206	$31,576
2024	80	520	$49,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	100	$59,766
2016	27	127	$43,044
2017	96	340	$71,411
2018	165	598	$68,048
2019	113	416	$34,709
2020	54	174	$10,598
2021	67	288	$15,827
2022	65	340	$9,019
2023	N/R	16	$673
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	46	46	$174
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	74	$147
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	651	733	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	57	108	$101
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	70	157	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	11	390	$7,774
Levothyroxine Sodium	Levothyroxine Sodium	19	1,710	$600
Amlodipine Besylate	Amlodipine Besylate	32	2,760	$446
Rosuvastatin Calcium	Rosuvastatin Calcium	12	1,080	$358
Atorvastatin Calcium	Atorvastatin Calcium	13	1,050	$238

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$33	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Armin Shahrokni, M.D?

Tedicare shows public-source Medicare data for Armin Shahrokni, M.D (NPI 1376776757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Armin Shahrokni, M.D have ACO affiliation data?

Armin Shahrokni, M.D is shown with ACO affiliation data for JFK Population Health LLC, JFK Health ACO (MSSP, ACO ID A2311).

What billing organization is linked to Armin Shahrokni, M.D?

Armin Shahrokni, M.D is linked to MEMORIAL MEDICAL CONSULTATION GROUP (billing NPI 1053382523) in the available physician profile data.

Does Armin Shahrokni, M.D have Open Payments data?

Armin Shahrokni, M.D has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.